Overview
Giorgia Gazzaroli practices practicing medicine in Brescia, Italy.
Her clinical expertise encompasses Adrenocortical Carcinoma, Adrenal Cancer, and Multiple Myeloma.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Giorgia Gazzaroli
Is Giorgia Gazzaroli a top-rated expert for Adrenocortical Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Giorgia Gazzaroli is classified as an Experienced expert for Adrenocortical Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Giorgia Gazzaroli participate in research or clinical trials?
Yes. Giorgia Gazzaroli has published 8 articles and abstracts on conditions like Adrenocortical Carcinoma. You can view a list of Giorgia Gazzaroli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal CancerMs. Gazzaroli isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaMs. Gazzaroli isExperienced. Learn about Adrenocortical Carcinoma.
- Multiple MyelomaMs. Gazzaroli isExperienced. Learn about Multiple Myeloma.